COVID-19 affects people with Parkinson’s disease in a similar way to the general population, but it may be more serious in cases of advanced disease.1
In a retrospective study with 80 kidney transplant patients with COVID-19, treatment with tocilizumab demonstrates a decrease in one of the inflammat1
Thrombosis, especially venous thrombosis, are one of the serious complications that can appear in patients affected by COVID-19. These complications,1
During the COVID-19 pandemic, allergists and other specialists such as pulmonologists, ENT specialists, internists and dermatologists have attended t1
People who have a haematological disease, such as lymphoma or leukaemia, present a state of immunosuppression caused both by the illness itself and t1
It has been observed that cardiovascular disease and COVID-19 are related in various ways, one of the most dangerous of which is patients with heart1
The SARS-CoV2 pandemic has impacted society in very diverse ways. Many people have changed their habits due to lockdown, such as practising physical1
The COVID-19 pandemic has raised concerns about the risk of people with different kinds of immunosuppression developing more serious forms of the inf1
Lockdown situations can lead to feelings of stress, frustration, guilt, or even anxiety in the general public. Also, people with mental disorders are1
The immune system of people with diseases like lupus or rheumatoid arthritis malfunctions and attacks cells in their own bodies. This is why they are1
